Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/23 02:09:45 am
42.345 EUR   +0.04%
02:05pBAYER : Request for Roundup Appeal Rejected by California Court
DJ
10/21BAYER : Monsanto loses final appeal over French farmer's weedkiller accident
RE
10/21BAYER AG : JP Morgan gives a Neutral rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
10/16/2020 10/19/2020 10/20/2020 10/21/2020 10/22/2020 Date
44.81(c) 44.33(c) 43.62(c) 42.5(c) 42.33(c) Last
5 245 029 2 461 100 3 116 377 5 096 131 4 219 432 Volume
+1.59% -1.07% -1.60% -2.57% -0.40% Change
More quotes
Financials
Sales 2020 42 935 M 50 758 M 50 758 M
Net income 2020 -5 435 M -6 426 M -6 426 M
Net Debt 2020 32 434 M 38 344 M 38 344 M
P/E ratio 2020 -6,40x
Yield 2020 5,74%
Sales 2021 43 334 M 51 230 M 51 230 M
Net income 2021 3 726 M 4 405 M 4 405 M
Net Debt 2021 31 442 M 37 171 M 37 171 M
P/E ratio 2021 11,9x
Yield 2021 5,76%
Capitalization 41 753 M 49 553 M 49 360 M
EV / Sales 2020 1,73x
EV / Sales 2021 1,69x
Nbr of Employees 101 168
Free-Float 100,0%
More Financials
Company
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Sales are distributed by product family as follows: - agrochemicals (45.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (41.2%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ; - OTC... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Notations Surperformance© of Bayer AG
Trading Rating : Investor Rating :
More Ratings
All news about BAYER AG
02:05pBAYER : Request for Roundup Appeal Rejected by California Court
DJ
10/21BAYER : Monsanto loses final appeal over French farmer's weedkiller accident
RE
10/21BAYER AG : JP Morgan gives a Neutral rating
MD
10/21BAYER AG : Morgan Stanley reiterates its Buy rating
MD
10/19Bayer's Orbia plans Latam expansion after Bunge deal in Brazil
RE
10/19BAYER AG : UBS keeps its Buy rating
MD
10/16BAYER : Leaps by Bayer leads USD 17 million Series B financing in biotech compan..
AQ
10/15BAYER : Leads Series B Financing in US Biotech Company
DJ
10/14BAYER : Phase 3 Lymphoma Study Meets Primary Endpoint
DJ
10/14BAYER : Combination of copanlisib and rituximab significantly prolonged progress..
PU
10/13BAYER AG : Barclays gives a Neutral rating
MD
10/12GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
10/12Industrials Up As Stimulus Worries Fade -- Industrials Roundup
DJ
10/12Correction to Bayer, BASF Weedkiller Fight Article on Oct. 11
DJ
10/12NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
News in other languages on BAYER AG
10:55aBörse Stuttgart-News: Euwax Trends
03:46aBAYER : verliert Rechtsstreit um Herbizid Lasso in Frankreich
10/21EUROPE : Les Bourses européennes reculent, échaudées par le Covid-19 et les Etat..
10/21FRANKFURT STOCK EXCHANGE : La Bourse de Francfort clôture dans le rouge, la cris..
10/21Börse Stuttgart-News: Euwax Trends
More news
Analyst Recommendations on BAYER AG
More recommendations
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 67,30 €
Last Close Price 42,50 €
Spread / Highest target 116%
Spread / Average Target 58,4%
Spread / Lowest Target 8,24%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Norbert Winkeljohann Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-41.63%49 553
JOHNSON & JOHNSON-1.33%378 942
ROCHE HOLDING AG-4.73%283 006
PFIZER INC.-4.31%206 049
MERCK & CO., INC.-14.16%197 458
NOVARTIS AG-16.89%186 106